investment analyst coverage
Wolfe Research Upgrades Danaher to Outperform
The upgrade is based on the firm's improving growth, more reasonable valuations, and its ability to deploy capital.
UBS Initiates Coverage of Veracyte With Buy Rating
Analysts noted that they envision "durable growth" in Veracyte's Afirma and Decipher Prostate tests and "long-term growth potential" from its MRD testing business.
Barclays Upgrades Revvity to Overweight
The firm's analysts wrote that they see stability in Revvity's diagnostics business and growth above peers in its life sciences and reagents business.
Craig-Hallum Upgrades QuidelOrtho to Buy
The investment bank said the company's core growth should accelerate as QuidelOrtho continues to penetrate the immunoassay market and expand its menu.
TD Cowen Initiates Coverage of Biodesix With Buy Rating
Analyst Dan Brennan wrote that lung nodule diagnostics is about a $4 billion market that is only about 1 percent penetrated, with Biodesix the only commercial player.
May 1, 2024
Craig-Hallum Upgrades CareDx to Buy
May 11, 2023
Barclays Initiates Coverage of Agilent
Nov 30, 2020